RBC Capital Markets BioTech Analyst Michael Yee and CastleArk Management President & CIO Jerry Castellini discuss the bull and bear cases for biotech stocks.» Read More
Martin Shkreli's attorney Benjamin Brafman explains why he thinks his client is a hero and why Congress meant to embarrass his client.
Martin Shkreli, the former drug company CEO who's come under fire for massive drug price increases, refused to testify Thursday before a congressional committee investigating drug price hikes.
Former Turing Pharmaceuticals CEO Martin Shkreli was escorted from a drug price hike hearing after pleading the Fifth Amendment. CNBC's Meg Tirrell reports on comments by Rep. John Duncan (R-Tenn.) on Shkreli's what he calls "arrogance."
"I intend to follow the advice of my counsel, and not yours," Martin Shkreli tells Rep. Trey Gowdy, smirking.
Former Turing Pharmaceuticals executive Martin Shkreli will appear before Congress this morning, reports CNBC's Meg Tirrell.
Florida Governor Rick Scott has declared a health emergency in four counties due to the Zika virus.
After his hearing at Brooklyn court on Wednesday, Martin Shkreli will no longer be speaking to the press according to his new lawyer.
Merck reported a 2.5 percent fall in quarterly revenue, hurt by a strong dollar and declining sales of its Remicade arthritis treatment.
U.K. drug store Boots has cut the prices on some of its products after it emerged it was charging women more than men for similar products.
Gilead Sciences Q4 EPS beat analysts' expectations, reports CNBC's Meg Tirrell.
Gilead reported quarterly earnings and revenue on Tuesday that beat analysts' expectations, boosted by sales of its drugs in Japan.
Kadmon, the biotechnology company founded by ImClone's Sam Waksal, is preparing to file confidentially for an initial public offering, sources say.
Sam Isaly, OrbiMed Advisors, discusses the biotech sector and how cases like the Zika virus impact the health sector.
Former drug CEO Martin Shkreli, facing fraud charges, hired a new lawyer who has previously represented Jay Z and Michael Jackson.
A possible vaccine for the Zika virus is still three to 10 years away, says Max Macaluso, an analyst at The Motley Fool.
Tourism and travel-related stocks have taken a hit from worries surrounding the Zika virus.
Drugmaker Abbott Laboratories said it would acquire Alere for $5.8 billion to boost its global diagnostics presence.
The Zika virus spreads through mosquitoes and can cause feverish symptoms and even birth defects. Oxitec, a subsidiary of Intrexon, is working on a genetically modified mosquito to help combat spreading the virus, with Intrexon CEO Randal Kirk.
The Zika virus should not cause Americans to be "unduly alarmed just yet," says infectious disease expert Paul Roepe.
Gilead Sciences on Friday that John Milligan, currently president and chief operating officer, will be promoted to CEO and appointed to the board of directors.
Get the best of CNBC in your inbox